By Meaghan Thurston
Canadian Institute for Advanced Research (CIFAR) program provides long-term, dedicated research funding to support and train the next generation of AI leaders.
This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.
Martha Crago, Vice-Principal, Research and Innovation, announced today that Kristina Öhrvall has been promoted to Assistant Vice-Principal, Research Development, for a five-year term.
Please note that Research and Innovation (R+I), including all of its associated units, will soon change to a summer schedule as per McGill’s policy on Summer Fridays.
In practice, this means R+I will function with only minimal staff on Fridays throughout the summer, from June 26 until August 21. R+I will resume regular weekly office hours on Friday, August 28.
Sent on behalf of Martha Crago, Vice-Principal (Research and Innovation)
I have been thinking of you often, as research is slowly starting up again at McGill.
The availability of reliable, rapid diagnostics is key to reopening our economies. Canada has an opportunity to take a leadership role in accelerating the development of these tests through a coordinated Canadian response. The goal is to support researchers to build networks and find collaborators/industry partners to advance their ideas to clinical trial and mass production. To that end, Dr.
McGill faculty with relevant expertise are encouraged to join the CanCOVID initiative, an expert community of Canadian COVID-19 researchers, clinical collaborators, and healthcare stakeholders.
Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus
On March 20, 2020, the Government of Quebec announced an immediate shutdown of constructions sites due to the COVID-19 pandemic. On April 7, it was announced that the date to resume construction activities is May 4, 2020. This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.
The COVID-19 pandemic and the present need to limit on-campus research has created unprecedented uncertainty for McGill Principal Investigators and the members of your teams. Specifically, many of you have shared your questions and concerns about renewing grant-based employment contracts for your research and laboratory staff – including postdocs, technicians, research assistants, and research associates – if their ability to work remains limited in the weeks and months ahead.
March 30, 2020
Good day everyone,
The staff at Environmental Health and Safety (EHS) would like to take this opportunity to send everyone well wishes during this unprecedented global crisis. We would like to thank you for the sacrifices you have made to help to “flatten the curve” so that everyone can resume their normal activities, including the very important research that happens at McGill, as soon as possible.
This message is sent on behalf of Martha Crago, Vice-Principal (Research and Innovation).
Dear members of the McGill research community,
The Code Life Ventilator Challenge needs help from compliance and IP experts for expedited review and mentoring of late-stage teams. Expert assistance is needed to ensure that any design can be reviewed and adjusted so as to ensure patient safety, and no IP rights infringement.
Sign up using this simple FORM.
The McGill Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and studies in this crisis.
The Public Health Agency of Canada has an urgent need for reagents for use in COVID-19 testing. The National Microbiology Lab (NML) is specifically looking for items on the list in the table below, as well as any other RNA extraction reagents.